Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Belief About Mandatory School Vaccinations and Vaccination Refusal Among Ohio Appalachian Parents: Do Demographic and Religious Factors, General Health, and Political Affiliation Play a Role?

Krok-Schoen JL, Bernardo BM, Weier RC, Peng J, Katz ML, Reiter PL, Richardson MS, Pennell ML, Tatum CM, Paskett ED.

J Rural Health. 2018 Jun;34(3):283-292. doi: 10.1111/jrh.12285. Epub 2017 Nov 14.

PMID:
29135050
2.

Partners for Kids Care Coordination: Lessons From the Field.

Weier RC, Gardner W, Conkol K, Pajer K, Kelleher KJ.

Pediatrics. 2017 May;139(Suppl 2):S109-S116. doi: 10.1542/peds.2016-2786E.

3.

Involving Community Health Workers in the Centers for Population Health and Health Disparities Research Projects: Benefits and Challenges.

Krok-Schoen JL, Weier RC, Hohl SD, Thompson B, Paskett ED.

J Health Care Poor Underserved. 2016;27(3):1252-66. doi: 10.1353/hpu.2016.0145.

PMID:
27524766
4.

Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls.

Paskett ED, Krok-Schoen JL, Pennell ML, Tatum CM, Reiter PL, Peng J, Bernardo BM, Weier RC, Richardson MS, Katz ML.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):593-602. doi: 10.1158/1055-9965.EPI-15-1243.

5.

The geographic distribution of cardiovascular health in the stroke prevention in healthcare delivery environments (SPHERE) study.

Roth C, Payne PR, Weier RC, Shoben AB, Fletcher EN, Lai AM, Kelley MM, Plascak JJ, Foraker RE.

J Biomed Inform. 2016 Apr;60:95-103. doi: 10.1016/j.jbi.2016.01.013. Epub 2016 Jan 29.

6.

Characterizing Community Health Workers on Research Teams: Results From the Centers for Population Health and Health Disparities.

Hohl SD, Thompson B, Krok-Schoen JL, Weier RC, Martin M, Bone L, McCarthy WJ, Noel SE, Garcia B, Calderón NE, Paskett ED.

Am J Public Health. 2016 Apr;106(4):664-70. doi: 10.2105/AJPH.2015.302980. Epub 2016 Jan 21.

7.

Study design, intervention, and baseline characteristics of a group randomized trial involving a faith-based healthy eating and physical activity intervention (Walk by Faith) to reduce weight and cancer risk among overweight and obese Appalachian adults.

Baltic RD, Weier RC, Katz ML, Kennedy SK, Lengerich EJ, Lesko SM, Reese D, Roberto KA, Schoenberg NE, Young GS, Dignan MB, Paskett ED.

Contemp Clin Trials. 2015 Sep;44:1-10. doi: 10.1016/j.cct.2015.06.017. Epub 2015 Jun 23.

8.

Participants' barriers to diagnostic resolution and factors associated with needing patient navigation.

Krok-Schoen JL, Brewer BM, Young GS, Weier RC, Tatum CM, DeGraffinreid CR, Paskett ED.

Cancer. 2015 Aug 15;121(16):2757-64. doi: 10.1002/cncr.29414. Epub 2015 Apr 28.

9.

Clinic type and patient characteristics affecting time to resolution after an abnormal cancer-screening exam.

Krok-Schoen JL, Kurta ML, Weier RC, Young GS, Carey AB, Tatum CM, Paskett ED.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):162-8. doi: 10.1158/1055-9965.EPI-14-0692. Epub 2014 Oct 13.

10.

Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.

Plascak JJ, Llanos AA, Pennell ML, Weier RC, Paskett ED.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2819-28. doi: 10.1158/1055-9965.EPI-14-0348. Epub 2014 Sep 9.

11.

Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship.

Bonafoux DF, Bonar SL, Clare M, Donnelly AM, Glaenzer JL, Guzova JA, Huang H, Kishore NN, Koszyk FJ, Lennon PJ, Libby A, Mathialagan S, Oburn DS, Rouw SA, Sommers CD, Tripp CS, Vanella LJ, Weier R, Wolfson SG, Huang HC.

Bioorg Med Chem. 2010 Jan 1;18(1):403-14. doi: 10.1016/j.bmc.2009.10.040. Epub 2009 Oct 27.

PMID:
19914076
12.

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman DD, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen JS.

J Rheumatol. 2008 May;35(5):869-76. Epub 2008 Mar 15.

PMID:
18381786
13.

Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.

Graneto MJ, Kurumbail RG, Vazquez ML, Shieh HS, Pawlitz JL, Williams JM, Stallings WC, Geng L, Naraian AS, Koszyk FJ, Stealey MA, Xu XD, Weier RM, Hanson GJ, Mourey RJ, Compton RP, Mnich SJ, Anderson GD, Monahan JB, Devraj R.

J Med Chem. 2007 Nov 15;50(23):5712-9. Epub 2007 Oct 19.

PMID:
17948975
14.

Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides.

Bonafoux D, Bonar S, Christine L, Clare M, Donnelly A, Guzova J, Kishore N, Lennon P, Libby A, Mathialagan S, McGhee W, Rouw S, Sommers C, Tollefson M, Tripp C, Weier R, Wolfson S, Min Y.

Bioorg Med Chem Lett. 2005 Jun 2;15(11):2870-5.

PMID:
15911271
15.

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.

Arthritis Rheum. 2005 Apr;52(4):1227-36. Erratum in: Arthritis Rheum. 2005 Sep;52(9):2951.

16.

A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.

Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, Huynh K, Bonar S, Mielke C, Albee L, Weier R, Graneto M, Hanau C, Perry T, Tripp CS.

J Biol Chem. 2003 Aug 29;278(35):32861-71. Epub 2003 Jun 17.

17.

Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.

Khanna IK, Yu Y, Huff RM, Weier RM, Xu X, Koszyk FJ, Collins PW, Cogburn JN, Isakson PC, Koboldt CM, Masferrer JL, Perkins WE, Seibert K, Veenhuizen AW, Yuan J, Yang DC, Zhang YY.

J Med Chem. 2000 Aug 10;43(16):3168-85.

PMID:
10956225
18.

Antiinflammatory 4,5-diarylimidazoles as selective cyclooxygenase inhibitors.

Barta TE, Stealey MA, Collins PW, Weier RM.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3443-8.

PMID:
9934449
19.

1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.

Khanna IK, Weier RM, Yu Y, Xu XD, Koszyk FJ, Collins PW, Koboldt CM, Veenhuizen AW, Perkins WE, Casler JJ, Masferrer JL, Zhang YY, Gregory SA, Seibert K, Isakson PC.

J Med Chem. 1997 May 23;40(11):1634-47.

PMID:
9171873
20.

1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.

Khanna IK, Weier RM, Yu Y, Collins PW, Miyashiro JM, Koboldt CM, Veenhuizen AW, Currie JL, Seibert K, Isakson PC.

J Med Chem. 1997 May 23;40(11):1619-33.

PMID:
9171872
21.

Alpha chain unsaturated derivatives of misoprostol.

Collins PW, Gasiecki AF, Weier RM, Kramer SW, Jones PH, Gullikson GW, Bianchi RG, Bauer RF.

Prostaglandins. 1987;33 Suppl:17-28.

PMID:
3122273
22.

Synthesis and gastrointestinal pharmacology of a 3E,5Z diene analogue of misoprostol.

Collins PW, Kramer SW, Gasiecki AF, Weier RM, Jones PH, Gullikson GW, Bianchi RG, Bauer RF.

J Med Chem. 1987 Jan;30(1):193-7.

PMID:
3100798
23.
24.

Mexrenoate potassium: a steroidal aldosterone antagonist and antihypertensive.

Hofmann LM, Weier RM, Suleymanov OD, Pedrera HA.

J Pharmacol Exp Ther. 1977 Jun;201(3):762-8.

PMID:
864608
26.

7alpha-Carboalkoxy steroidal spirolactones as aldosterone antagonists.

Weier RM, Hofmann LM.

J Med Chem. 1975 Aug;18(8):817-21.

PMID:
1159699

Supplemental Content

Support Center